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Background: Congenital anomalies and their primary prevention are a crucial public health issue. This work aimed
to estimate the prevalence of congenital anomalies in Brindisi, a city in southeastern Italy at high risk of
environmental crisis.
Methods: This research concerned newborns up to 28 days of age, born between 2001 and 2010 to mothers
resident in Brindisi and discharged with a diagnosis of congenital anomaly. We classified cases according to the
coding system adopted by the European Network for the Surveillance of Congenital Anomalies (EUROCAT).
Prevalence rates of congenital anomalies in Brindisi were compared with those reported by EUROCAT. Logistic
regression models were adapted to evaluate the association between congenital anomalies and municipality of
residence of the mother during pregnancy.
Results: Out of 8,503 newborns we recorded 194 subjects with congenital anomalies (228.2/10,000 total births), 1.2
times higher than the one reported by the EUROCAT pool of registries. We observed 83 subjects with congenital
heart diseases with an excess of 49.1%. Odds Ratios for congenital heart diseases significantly increased for
newborns to mothers resident in Brindisi (OR 1.75 CI 95% 1.30-2.35).
Conclusions: Our findings indicated an increased prevalence of Congenital Anomalies (especially congenital heart
diseases) in the city of Brindisi. More research is needed in order to analyze the role of factors potentially involved
in the causation of congenital anomalies.
Keywords: Congenital anomalies, Hospital discharge data, Surveillance of birth defects, Registers of congenital
anomaliesBackground
Congenital anomalies (CAs) and their primary preven-
tion are an important public health issue and both gen-
etic and environmental factors can contribute to their
causation [1]. According to Dolk [2], “Environmental
factors include any non-genetic factor that increases the
risk of a birth defect for the exposed individual. Such
factors are nutritional excesses or deficiencies (e.g. folic
acid), maternal illness or infection (e.g. diabetes, rubella),
drugs taken during pregnancy (e.g. thalidomide), chem-
ical exposure in the workplace or home (e.g., to solvents
or pesticides) and radiation (e.g., medical X-ray).”* Correspondence: emilio.gianicolo@ifc.cnr.it
1National Research Council, Institute of Clinical Physiology, Campus Ecotekne
Building A7, Via per Monteroni, 73100, Lecce, Italy
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reproduction in any medium, provided the orScientific literature is interested in the association be-
tween CAs and the possible role of chemical contami-
nants [3], and fetuses are thought to be a further
subgroup of the population who could be vulnerable to
the effects of air pollutants [4,5].
Brindisi is a town in the Apulia region of southeastern
Italy and has a population of about 90,000, covering an
area of almost 330 km2 with a population density of
271.9 inhabitants per km2. Brindisi is the capital of the
homonymous province, which has a population of about
402,800 and covers an area of 1,839 km2 with a popula-
tion density of 219.2 inhabitants per km2.
Many sources of pollution are located near the urban
area: a huge petrochemical plant, chemical, pharmaceu-
tical, metallurgical and manufacturing plants, an incine-
rator and three power plants, two of which are coal-fired,al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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http://www.biomedcentral.com/1471-2393/12/165producing around 4,400 Megawatts (Figure 1). Moreover,
illegal dumps have been found, and the airport and
maritime ports, both located in town, have also increased
their activity.
In the 1980s, Brindisi and its surrounding municipalities
were identified by the Italian Ministry of Environment as
an “area at high risk of environmental crisis” [6] and in
1998 the town was included among the 57 sites of the
national program of environmental remediation [7]. Epi-
demiological studies have revealed several critical situa-
tions in terms of increasing rates of mortality and
morbidity associated with environmental and occupational
exposure to pollutants [8-12]. Recently, an analysis of air
quality data carried out for the period 1992–2007 revealed
the influence of both the industrial area and the harbor on
air pollutant concentration in Brindisi [13]. Very recently,
although with imprecision due to broad confidence inter-
vals, standardized mortality ratios for congenital anomal-
ies in all ages were observed to be higher than expected
(regional reference) in the period 1995–2001 [14]. The
authors suggested a plausible role of environmentalFigure 1 The area of the study: emission sources and population denexposure and they hypothesized the etiological role of pol-
lutants produced both by the petrochemical plant and by
dumps [14].
Given this context and in absence of a CA registry, the
aim of this study was to estimate the prevalence of con-
genital anomalies in Brindisi from hospital discharge
data (HDD) among newborns in Brindisi between 2001
and 2010 and to compare them with prevalence rates
reported by the European network for the surveillance
of congenital anomalies (EUROCAT).
Methods
This study concerned newborns 0–28 days of age, born
between 2001 and 2010 to mothers resident in Brindisi
and discharged with a diagnosis of CA. Data were
extracted from the HDD of the local health unit, which
is the regional government unit that holds health records
for the entire province of Brindisi, including those
related to births. HDD included information on cumula-
tive personal files and healthcare records on diagnoses,
the main one and up to five for each discharge record,sity.
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eases - Clinical Modification, 9th Revision (ICD-9-CM).
We considered as cases the newborns with a CA recorded
in any of the diagnostic fields. The groups of congenital
anomalies analyzed and corresponding ICD-9-CM codes
are reported in Table 1.
We classified cases in the following categories: total
CAs, congenital heart disease (CHDs) and other CAs
according to the coding system adopted by the European
Network for the Surveillance of Congenital Anomalies -
EUROCAT. Subcategories of CHDs with at least five







Ear. face and neck 744
Congenital heart disease 745-746, 747–747.4
-Common arterial truncus 745.00
-Transposition of great vessels 745.10
-Single ventricle 745.3
-Ventricular septal defect 745.4
-Atrial septal defect 745.5
-Atrioventricular septal defect 745.6
-Tetralogy of Fallot 745.2
-Tricuspid atresia and stenosis 746.1
-Ebstein’s anomaly 746.2
-Pulmonary valve atresia 746.01
-Pulmonary valve stenosis 746.02
-Aortic valve atresia / stenosis 746.3
-Hypoplastic left heart 746.7
-Coarctation of aorta 747.1





Digestive system 750-751, 756.6
Abdominal wall defects 756.70-756.71, 756.79
Urinary 753, 756.72, 752.62
-Bladder exstrophy and / or
epispadia
753.5, 752.62
Genital 752.0-752.4, 752.60, 752.61, 752.7-752.9
-Hypospadia 752.61
Limb 754.3-754.8, 755
Musculo-skeletal 754.0-754.2, 756.0-754.5, 756.8-756.9,
762.80
Chromosomal 758.0-758.3, 758.5-758.9
Other malformations 747.5-747.9, 757, 759.0-759.7Registries in EUROCAT register information about
newborns and the mothers using different data sources
[15]. Registries in EUROCAT use the code system of the
British Paediatric Association Classification of Diseases
ICD-9-BPA, which is a five-digit extension of the ninth
revision of the International Classification of Diseases
(ICD-9). Thus, in order to have comparable data set we
used the corresponding ICD-9-CM codes.
We adopted EUROCAT exclusion criteria for minor
anomalies with less medical, functional or cosmetic im-
portance [16]. We excluded cases with patent ductus
arteriosus (PDA) in preterm babies (< 37th gestational
week) [16]. For this purpose, in order to correctly iden-
tify the gestational week (information not recorded on
HDD) it was necessary to recover each case-history.
All cases of CA with more than one anomaly were
counted only once in the “Total CAs” category.
We calculated observed/expected ratios with 95% con-
fidence interval (CI 95%) [17]: expected cases (E) were
obtained by multiplying the proportion of newborns
with CAs in the pool of EUROCAT registries [18] by the
number of live births to mothers resident in Brindisi.
For each category of CAs, we calculated a rate ratio
(RR) obtaining by dividing the prevalence ratios observed
among males by the prevalence ratio observed among
females [19].
We classified CHDs in the following three classes
according to their severity defined on the basis of peri-
natal mortality rates: Severity I (high perinatal mortality);
Severity II (medium perinatal mortality); Severity III
(low perinatal mortality) [20]. We also classified CHDs
according to the presence or absence of an associated
chromosomal anomaly [20].
Together with expert neonatologists and a geneticist,
we analyzed 994 records extracted from HDD (11.7% of
the total population of newborns) admitted to the local
Neonatal Intensive Care Unit (NICU) and registered in
an independent and more detailed archive, in order to
evaluate the validity of the diagnosis reported in the
HDD. Sensitivity, specificity, and positive and negative
predictive (PPV and PPN) values were thus calculated in
order to estimate validity [21].
For local comparison purposes logistic regression mod-
els, adjusted at municipality level for a social economic
deprivation index [22] and for maternal average age at de-
livery, were adapted to evaluate the association between
CAs/CHDs and municipality of residence of the mother
during pregnancy. For this purpose, municipalities were
grouped into three categories: Brindisi, neighboring muni-
cipalities and outlying municipalities in Brindisi province.
Statistical analysis was performed using SAS statistical
software (SAS Institute Inc, Cary, NC, USA) version 8.2
for Microsoft Windows (Microsoft Corporation, Redmont,
WA, USA).
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committee of the Brindisi local health unit approved our
research. Research was in compliance with the Helsinki
Declaration. Written informed consent from the parents
was obtained.
Results
Table 2 reports the prevalence rates and the ratio of
observed/expected number of anomalies based on the
pool of EUROCAT registries. Out of 8,503 live births to
mothers resident in Brindisi, 194 newborns showed CAs,
83 a CHD. The prevalence rate of total CAs was 228.2/
10,000 newborns. The expected number of cases was 165.5
and the ratio O/E = 117.2 (95% CI 101.8-134.9; p < 0.05)
(Table 2). The prevalence rate for the CHDs was 97.6 and
the ratio O/E = 149.1 (95% CI 120.2-184.8; p < 0.001).
Excesses were observed for each of the subcategories of
CHDs considered, with strong evidence against the null hy-
pothesis for Ventricular Septal Defect (179.6; 95% CI 133.7-
241.3; p < 0.001) and Pulmonary Valve Stenosis (267.6; 95%
CI 133.4-533.2; p < 0.01) (Table 2). Observed cases of Other
CAs were close to the expected ones (Table 2).
Out of 83 cases with CHD, we observed 9 cases
(10.8%) with medium probability of perinatal mortality
(Severity II) and 69 cases (83.1%) with low probability of
perinatal mortality (Severity III). No case with high
probability of perinatal mortality was registered. Five
cases (6%) were not classified because of a poorly speci-
fied code. Two cases of CHDs (2.4%) were associated
with a chromosomal anomaly.
CAs were more frequent among males (RR = 1.42,
95% CI 1.07-1.89; p < 0.05, not shown in table).
Of 8,503 newborns from mother resident in Brindisi,
994 (11.7%) were admitted to the NICU division and
registered in an independent and very detailed archive,
which was used for validation purposes. A total of 45
out of 65 met the case definition for one of the majorTable 2 Newborns with congenital anomalies born to mother




Cases observed Rates x 10,000 livebirths
All anomalies c 194 228.2
Congenital heart disease 83 97.6
- Ventricular septal defect 44 51.7
- Atrial septal defect 17 20.0
- Pulmonary valve stenosis 8 9.4
Other congenital anomalies 122 143.5
a *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.
b Pool of Italian registries.
c Cases of CAs with more than one anomaly were counted only once in “All anoma
than one CA.
Absolute values, rates for 10,000 live births, O/E ratios and CI 95%.
City of Brindisi, 2001–2010.CAs (Table 3) and 24 out of 25 children for CHD (Table 3).
Therefore, sensitivity was 69.2% and 96% respectively. The
specificity was in both cases almost 100%. PPV was 73.8%
for all CAs and 85.7% for CHDs; NPV was 97.9% and
99.9% respectively.
In municipalities neighboring Brindisi 8,669 cases of
CAs were observed; 17,523 cases were registered in the
outlying municipalities in Brindisi province. The preva-
lence of CAs is more frequent among newborns to
mothers resident in the city of Brindisi (Table 4). Odds
Ratios for CHDs were significantly higher in the city of
Brindisi (OR = 1.85; 95% CI: 1.36-2.50) then in the out-
lying municipalities in Brindisi province (Table 5).
Discussion
Our findings indicated prevalence rate of CAs, and in
particular of CHDs, was higher in Brindisi than those
reported by the pool of EUROCAT registries and those
observed in neighboring municipalities.
For this analysis, 28 days was chosen as maximum age
for the diagnosis of CAs; this cut-off might induce a bias
comparison since in EUROCAT registries the maximum
age for diagnosis has a wide range of variation (1 week
to 15 years) [15].
Registries are one of the most accurate approaches
in terms of case ascertainment and diagnostic detail,
thus assuring reliability in estimating prevalence rates
of CAs and a valid base of surveillance systems [23].
Nevertheless, limited resources in birth defect surveil-
lance programs sometimes require the use of elec-
tronic health archives – already available and designed for
administrative purposes – for surveillance by public health
researchers [24].
The HDD archive is increasingly used to estimate the oc-
currence of a wide range of diseases and more recently also
to estimate neonatal morbidity and birth defects [25].
HDD were originally designed for administrative purposes,s resident in the city of Brindisi and comparison with the
Pool of EUROCAT registers p a
Rates x 10,000 livebirths Expected (O/E)x100 95% CI
194.6 165.5 117.2 101.8-134.9 *
65.4 55.7 149.1 120.2-184.8 ***
28.8 24.5 179.6 133.7-241.3 ***
19.9 16.9 100.7 62.5-161.8
3.5 3.0 267.6 133.4-533.2 **
153.9 130.9 93.2 78.1-111.3
lies” category. Numbers do not add up because of newborns with more
Table 3 Validity of hospital discharge data for identifying




Yes % No % Total
ALL CONGENITAL ANOMALIES
Yes 45 73.8 16 26.2 61
No 20 2.1 913 97.9 933




95% CI (57.3 -
79.5)





95% CI (61.7 -
83.6)
95% CI (96.8 -
98.7)
CONGENITAL HEART DISEASE
Yes 24 85.7 4 14.3 28
No 1 0.1 965 99.9 966




95% CI (81.8 -
99.8)





95% CI (99.2 -
99.9)
95% CI (99.5 -
100.0)
City of Brindisi, at single NICU facility, 2001–2010.
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source of epidemiological information on large patient
populations [25]. Although issues have been raised regard-
ing geographic variability of archive quality and complete-
ness [26], HDD are considered an important source of
information to estimate diseases such as CAs [27].
Together with expert neonatologists and a geneticist,
we observed a subset of cases admitted to the NICU
and registered in an independent and more detailed
archive, in order to evaluate the validity of the diagno-
sis reported in the HDD. High frequencies of diagnoses
correctly recorded was observed. Nevertheless, the vali-
dity study was conducted only on a single hospital [21],Table 4 Newborns and cases of CAs according to the residenc






City of Brindisi 8,503
Municipalities neighboring Brindisi 8,669
Outlying municipalities in Brindisi province 17,523
a Cases with diagnosis of PDA were excluded due to the impossibility of identifying
other than Brindisi.
Absolute values and rates for 10,000 live births.
Province of Brindisi, 2001–2010.so the validity of data in other Italian areas must be fur-
ther demonstrated.
This study could not have identified cases of infants
with a CA born at home. Nevertheless, according to the
National Institute of Statistics [28], in Italy the percentage
of births not occurring in public or private hospitals is
0.1% and it is mainly concentrated in the northern part of
Italy. Therefore, this phenomenon can be assumed to be
rare in the investigated area and it would not have had
any effect on the estimated prevalence of CAs.
Our results on sex differences confirm those reported
in literature regarding an increased risk among male
newborns [29].
It has recently been suggested that environmental risk
factors might play an important role in the etiology of
CHD [30-32].
Environmental pollutants of concern for health impact
include a wide range of airborne contaminants such as
nitrogen dioxide (NO2), sulfur dioxide (SO2), carbon
monoxide (CO), ozone (O3); particulate matter (PM)
and heavy metals (specifically cadmium, lead, mercury,
chromium and arsenic), and organic compounds, specif-
ically dioxins and furans, polychlorinated biphenyls
(PCBs), and polycyclic aromatic hydrocarbons (PAHs).
Their main sources are traffic, industrial emissions and
hazardous waste sites. In recent years, population-based
and case–control studies have reported an increased risk
of congenital anomalies in polluted areas, especially for
selected congenital heart defects [30,33-39].
Some important limitations must be considered when
interpreting the results of this study.
First, environmental data at the individual or eco-
logical level were not available.
Secondly, we were not able to adjust our analysis for
potential confounding factors that are known or sus-
pected to increase the risk of congenital anomalies, such
as maternal diabetes, smoking, parental occupation and
social determinants, because they were unavailable in
the HDD archives [40,41].
Thirdly, data covered live births only. In estimating
the prevalence of CAs in a population, stillbirths and
pregnancy terminations should be taken into account.
Many fetuses die in utero and technological advances ine of the mother during pregnancy
ongenital anomalies Cases with CHDsa
alues Cases x 10,000 Absolute values Cases x 10,000
193 227.0 82 96.4
157 181.1 57 65.8
360 205.4 99 56.5
the exact gestational week for newborns to mothers resident in municipalities
Table 5 Crude and adjusted ORs (95% CI) for CAs and CHDs residence of the mother during pregnancy
Residence of the mother during pregnancy Unadjusted Adjustedb
OR CI 95% Pa OR CI 95% Pa
ALL CONGENITAL ANOMALIES
Outlying municipalities in Brindisi province (reference) 1 1
City of Brindisi 1.13 0.95-1.35 1.13 0.94-1.35
Municipalities neighbour to Brindisi 0.90 0.74-1.09 0.85 0.69-1.05
CONGENITAL HEART DISEASE
Outlying municipalities in Brindisi province (reference) 1 1
City of Brindisi 1.75 1.30-2.35 *** 1.85 1.36-2.50 ****
Municipalities neighbour to Brindisi 1.19 0.86-1.66 1.08 0.75-1.55
a *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.
b Models are adjusted at municipality level for a social economic deprivation index and for average maternal age at delivery.
Province of Brindisi, 2001–2010.
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mination of pregnancy. This is a very important issue
that needs to be addressed in estimating prevalence of
CAs but could not be tackled in the present study. How-
ever, although the frequency of voluntary abortion in
Italy in the years 2006–2007 (230 x 1,000 newborns) was
lower than the European one (244) [42], in Apulia the
frequency was much higher (304) than in the other
Italian regions [43]. Thus, the higher CA rates observed
in Brindisi might not be biased by pregnancy terminations.
However, this aspect together with the study of incidents
of CAs among stillbirths should be further investigated.
Conclusions
Our data showed the validity of HDD in estimating the
prevalence of CAs in the city of Brindisi. Furthermore,
an increased prevalence of CAs (especially CHDs) in the
city of Brindisi, known to be an area at high risk of
environmental crisis, was observed. More research in
terms of etiological studies is needed, in order to analyze
the role of different risk factors in the possible causation
of CAs. In this work we did not have any personal or
ecological exposure data. Therefore, it was impossible to
infer about the possible role of pollution. Nevertheless,
our working group is now focusing on exposure data
and on the correlation between environmental data and
health data. This will be the aim of our next paper.
Results from this kind of study ought to reduce this
burden through identifying the best strategies for pri-
mary prevention.Abbreviations
CAs: Congenital Anomalies; HDD: Hospital Discharge Data;
EUROCAT: European Surveillance of Congenital Anomalies; ICD-9-
CM: International Classification of Diseases - Clinical Modification, 9th
Revision; CHDs: Congenital Heart Diseases; PDA: Patent Ductus Arteriosus;
NICU: Neonatal Intensive Care Unit; PPV: Positive Predictive Value;
PPN: Negative Predictive Value; CI: Confidence Interval; E: Expected;
O: Observed; RR: Rate Ratio; NO2: Nitrogen Dioxide; SO2: Sulfur Dioxide;CO: Carbon Monoxide; O3: Ozone; PM: Particulate Matter;
PCBs: Polychlorinated Biphenyls; PAHs: Polycyclic Aromatic Hydrocarbons.
Competing interests
The authors declare no competing interests.
Authors’ contributions
EALG, analyzed data, reviewed the literature and was the main contributor to
writing the manuscript. AB, managed the newborns data, the record linkage
and contributed to writing the manuscript. ER, contributed in analysing each
case-history and validating the diagnosis of congenital anomalies. SS and RG
were responsible for data recovery from NICU data set and contributed to
writing the manuscript. GP and LC provided Hospital Discharge Data. MAV
and MGA reviewed the literature and the final manuscript. GL, was Senior
Physician and contributed to writing the manuscript. All authors read and
approved the final manuscript.
Acknowledgements
The National Research Council, Institute of Clinical Physiology of Lecce
conducted this study in cooperation with the Division of Neonatology,
Perrino Hospital of Brindisi. This work was partially supported by the Italian
Association for the Study of Malformations - Associazione Italiana per lo
Studio delle Malformazioni (ASM Onlus).
We wish to thank Alison Frank for helping revise and edit the English. We
acknowledge Mr. Cosimo Saracino for helping recover patients’ case-history
and acknowledge professor Eugenio Picano for useful discussions.
Author details
1National Research Council, Institute of Clinical Physiology, Campus Ecotekne
Building A7, Via per Monteroni, 73100, Lecce, Italy. 2Division of Neonatology,
Perrino Hospital, Brindisi, Italy. 3National Research Council, Institute of Clinical
Physiology, Pisa, Italy. 4Local Health Unit, Brindisi, Italy. 5University of Pisa,
Pisa, Italy.
Received: 11 April 2012 Accepted: 18 December 2012
Published: 27 December 2012
References
1. Dolk H, Loane M, Garne E: The prevalence of congenital anomalies in
Europe. Adv Exp Med Biol 2010, 686:349–364.
2. Dolk H: Epidemiological evidence regarding environmental causes of
congenital anomalies: interpretational issues. In EUROCAT special report:
A Review of Environmental Risk Factors for Congenital Anomalies. Co Antrim
Northern Ireland: University of Ulster Newtownabbey; 2004:30–47.
3. Dolk H: Epidemiological approaches to identifying environmental causes
of birth defects. Am J Med Genet C Semin Med Genet 2004, 125C(1):4–11.
4. Pope CA 3rd: Epidemiology of fine particulate air pollution and human
health: biologic mechanisms and who's at risk? Environ Health Perspect
2000, 108(Suppl. 4):713–723.
Gianicolo et al. BMC Pregnancy and Childbirth 2012, 12:165 Page 7 of 7
http://www.biomedcentral.com/1471-2393/12/1655. Perera FP, Jedrychowski W, Rauh V, Whyatt R: Molecular epidemiologic
research on the effects of environmental pollutants on fetus. Environ
Health Perspect 1999, 107(suppl):451–460.
6. Law of the Italian Parliament of 8 July 1986, n.349: “Istituzione del Ministero
dell'ambiente e norme in materia di danno ambientale ", published on
Supplemento ordinario n.59 alla Gazzetta Ufficiale. n. 162, 15 July 1986; 1986.
7. Law of the Italian Parliament of 9 December 1998, n. 426: "Nuovi interventi
in campo ambientale", published on Gazzetta Ufficiale n. 291, 14 december
1998; 1998.
8. Martuzzi M, Mitis F, Biggeri A, Terracini B, Bertollini R: Environment and
health status of the population in areas with high risk of environmental
crisis in Italy. Epidemiol Prev 2002, 26(6 Suppl):1–53.
9. Belli S, Benedetti M, Comba P, Lagravinese D, Martucci V, Martuzzi M,
Morleo D, Trinca S, Viviano G: Case–control study on cancer risk
associated to residence in the neighbourhood of a petrochemical plant.
Eur J Epidemiol 2004, 19(1):49–54.
10. Gianicolo EA, Serinelli M, Vigotti MA, Portaluri M: Mortality in the
municipalities of Brindisi Province, 1981–2001. Epidemiol Prev 2008,
32(1):49–57.
11. Serinelli M, Gianicolo EA, Cervino M, Mangia C, Portaluri M, Vigotti MA:
Acute effects of air pollution in Brindisi (Italy): a case-crossover analysis.
Epidemiol Prev 2010, 34(3):100–107.
12. Calculli C, Pollice A, Serinelli M: Spatial analysis of the risk of multiple
cancers in relation to a petrochemical plant. Environmetrics 2011,
23:175–182.
13. Mangia C, Bruni A, Cervino M, Gianicolo EAL: Sixteen-year air quality data
analysis of a high environmental risk area in Southern Italy. Environ Monit
Assess 2011, 183(1–4):555–570.
14. Pirastu R, Zona A, Ancona C, Bruno C, Fano V, Fazzo L, Iavarone I, Minichilli
F, Mitis F, Pasetto R, Comba P: SENTIERI project - mortality study of
residents in Italian polluted sites: RESULTS. Epidemiol Prev 2011,
35(5–6):59–61. Suppl. 4.
15. Greenlees R, Neville A, Addor MC, Amar E, Arriola L, Bakker M, Barisic I, Boyd
PA, Calzolari E, Doray B, Draper E, Vollset SE, Garne E, Gatt M, Haeusler M,
Kallen K, Khoshnood B, Latos-Bielenska A, Martinez-Frias ML, Materna-Kiryluk
A, Dias CM, McDonnell B, Mullaney C, Nelen V, O'Mahony M, Pierini A,
Queisser-Luft A, Randrianaivo-Ranjatoélina H, Rankin J, Rissmann A, Ritvanen
A, Salvador J, Sipek A, Tucker D, Verellen-Dumoulin C, Wellesley D,
Wertelecki W: Paper 6: EUROCAT member registries: organization and
activities. Birth Defects Res A Clin Mol Teratol 2011, 91(Suppl. 1):S51–S100.
16. EUROCAT (European Surveillance of Congenital Anomalies): EUROCAT Guide
1.3 and reference documents. Instructions for the Registration and Surveillance
of Congenital Anomalies; 2005. [http://www.eurocat-network.eu/content/
EUROCAT-guide-1.3.pdf.] Accessed 30th November 2011.
17. Rothman KJ, Greenland S, Lash TL: Modern Epidemiology. 3rd edition.
Philadelphia, PA: Lippincott Williams & Wilkins; 2008.
18. EUROCAT (European Surveillance of Congenital Anomalies): Access
prevalence data. Prevalence tables; 2011. [http://www.eurocat-network.eu/
accessprevalencedata/prevalencetables] Accessed 30th November 2011.
19. Lary JM, Paulozzi LJ: Sex differences in the prevalence of human birth
defects: a population-based study. Teratology 2001, 64(5):237–251.
20. Dolk H, Loane M, Garne E: European surveillance of congenital anomalies
(EUROCAT) working group. congenital heart defects in Europe: prevalence
and perinatal mortality, 2000 to 2005. Circulation 2011, 123(8):841–849.
21. Frohnert BK, Lussky RC, Alms MA, Mendelsohn NJ, Symonik DM, Falken MC:
Validity of hospital discharge data for identifying infants with cardiac
defects. J Perinatol 2005, 25:737–742.
22. Caranci N, Biggeri A, Grisotto L, Pacelli B, Spadea T, Costa G: The Italian
deprivation index at census block level: definition, description and
association with general mortality. Epidemiol Prev 2010, 34(4):167–176.
23. Lechat MF, Dolk H: Registries of congenital anomalies: EUROCAT.
Environ Health Perspect 1993, 101(Suppl 2):153–157.
24. Wang Y, Cross PK, Druschel CM: Hospital discharge data: can it serve as
the sole source of case ascertainment for population-based birth defects
surveillance programs? J Publ Health Manag Pract 2010, 16(3):245–251.
25. Baldi I, Vicari P, Di Cuonzo D, Zanetti R, Pagano E, Rosato R, Sacerdote C,
Segnan N, Merletti F, Ciccone G: A high positive predictive value
algorithm using hospital administrative data identified incident cancer
cases. J Clin Epidemiol 2008, 61(4):373–379.
26. Simonato L, Baldi I, Balzi D, Barchielli A, Battistella G, Canova C, Cesaroni G,
Corrao G, Collini F, Conti S, Costa G, Demaria M, Fornari C, Faustini A, GalassiC, Gnavi R, Inio A, Madotto F, Milgliore E, Minelli G, Pellizzari M, Protti M,
Romanelli A, Russo A, Saugo M, Tancioni V, Tessari R, Vianello A, Vigotti MA:
Objectives, tools and methods for an epidemiological use of electronic
health archives in various areas of Italy. Epidemiol Prev 2008,
32(3 Suppl):5–14.
27. ISTAT: Frequencies of congenital malformation diagnosis. Statistic information
system on disability; 2006. [www.disabilitaincifre.it/descrizioni/Malformazioni.
pdf]. Accessed 30th November 2011.
28. ISTAT: National survey on Health conditions and recourse to health services
2004–2005; 2010. [http://www.istat.it/it/archivio/7740]. Accessed 15th
October 2012.
29. Øyen N, Poulsen G, Boyd HA, Wohlfahrt J, Jensen PK, Melbye M: Recurrence
of congenital heart defects in families. Circulation 2009, 120:295–301.
30. Ritz B, Yu F, Fruin S, Chapa G, Shaw GM, Harris JA: Ambient air pollution
and risk of birth defects in Southern California. Am J Epidemiol 2002,
55:17–25.
31. Gianicolo EA, Cresci M, Ait-Ali L, Foffa I, Andreassi MG: Smoking and
congenital heart disease: the epidemiological and biological link.
Curr Pharm Des 2010, 16(23):2572–2577.
32. Cresci M, Foffa I, Ait-Ali L, Pulignani S, Gianicolo EAL, Botto N, Picano E,
Andreassi MG: Maternal and paternal environmental risk factors,
metabolizing GSTM1 and GSTT1 polymorphisms, and congenital heart
disease. Am J Cardiol 2011, 108(11):1625–1631.
33. Dolk H, Vrijheid M: The impact of environmental pollution on congenital
anomalies. Br Med Bull 2003, 68:25–45.
34. Gilboa SM, Mendola P, Olshan AF, Langlois PH, Savitz DA, Loomis D, Herring
AH, Fixler DE: Relation between ambient air quality and selected birth
defects, seven county study, Texas, 1997–2000. Am J Epidemiol 2005,
162:238–252.
35. Hansen CA, Barnett AG, Jalaludin BB, Morgan GG: Ambient air pollution
and birth defects in Brisbane, Australia. PLoS One. 2009, 4(4):e5408.
36. Rankin J, Chadwick T, Natarajan M, Howel D, Pearce MS, Pless-Mulloli T:
Maternal exposure to ambient air pollution and risk of congenital
anomalies. Environ Res 2009, 109:181–187.
37. Strickland MJ, Klein M, Correa A, Reller MD, Mahle WT, Riehle-Colarusso SJ,
Botto LD, Flanders WD, Mulholland JA, Siffel C, Marcus M, Tolbert PE:
Ambient air pollution and cardiovascular malformations in Atlanta,
Georgia, 1986–2003. Am J Epidemiol 2009, 169:1004–1014.
38. Dolk H, Armstrong K, Vrijheid M, Lachowycz K, Rankin J, Abramsky L, Boyd
PA, Wellesley D: Ambient air pollution and risk of congenital anomalies in
England, 1991–1999. Occup Environ Med 2010, 67:223–227.
39. Dadvand P, Rankin J, Rushton S, Pless-Mulloli T: Ambient air pollution and
congenital heart disease: a register-based study. Environ Res 2011,
111(3):435–441.
40. Morales-Suárez-Varela MM, Bille C, Christensen K, Olsen J: Smoking habits,
nicotine use, and congenital malformations. Obstet Gynecol 2006,
107(1):51–57.
41. Varela MM, Nohr EA, Llopis-González A, Andersen AN, Olsen J: Socio-
occupational status and congenital anomalies. Eur J Publ Health 2009,
19(2):161–167.
42. World Health Organization (WHO) Regional Office for Europe: European
health for all database (HFA-DB) 2011; 2011. Available: [http://data.euro.who.
int/hfadb/]. Accessed 30th November 2011.
43. Italian Ministry of Health. Ministry of health report on the social protection
of motherhood and voluntary termination of pregnancy (low 194/78),
Italian Ministry of Health: Ministry of health report on the social protection of
motherhood and voluntary termination of pregnancy (low 194/78); 2008.
Available: [http://www.salute.gov.it/imgs/C_17_pubblicazioni_804_allegato.
pdf]. Accessed 30th November 2011.
doi:10.1186/1471-2393-12-165
Cite this article as: Gianicolo et al.: Congenital anomalies among live
births in a polluted area. A ten-year retrospective study. BMC Pregnancy
and Childbirth 2012 12:165.
